CAN ONABOTULINUMTOXINA IMPROVE SYMPTOMS AND QUALITY OF LIFE IN ALL PATIENTS WITH OVERACTIVE BLADDER, REGARDLESS OF DISEASE DURATION OR BODY MASS INDEX?

被引：0

作者：

Chermansky, C. ^{[1
]}

Rechberger, T. ^{[2
]}

Miles-Thomas, J. ^{[3
]}

Hale, D. ^{[4
]}

Cardozo, L. ^{[5
]}

Orejudos, A. ^{[6
]}

Patel, A. ^{[7
]}

Herschorn, S. ^{[8
]}

机构：

[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[2] Med Univ Lublin, Lublin, Poland

[3] Urol Virginia, Virginia Beach, VA USA

[4] Urogynecol Associates Pc, Indianapolis, IN USA

[5] Kings Coll Hosp London, London, England

[6] Allergan Plc, Irvine, CA USA

[7] Allergan Plc, Marlow, Bucks, England

[8] Univ Toronto, Toronto, ON, Canada

来源：

关键词：

PLACEBO-CONTROLLED TRIAL; URINARY-INCONTINENCE; DOUBLE-BLIND;

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

270

引用

页码：S219 / S220

页数：2

共 12 条